| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |